查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1807187

兒童糖尿病管理市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、技術、最終用戶、地區和競爭細分，2020-2030 年）

Pediatric Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球兒童糖尿病管理市場價值為 56.6 億美元，預計到 2030 年將達到 100.1 億美元，複合年成長率為 9.94%。由於兒童和青少年的糖尿病盛行率不斷上升，全球兒童糖尿病管理市場正在經歷顯著成長，這推動了對創新管理解決方案的需求。兒童糖尿病，尤其是第 1 型糖尿病，需要持續監測和精確的胰島素注射，以預防糖尿病酮症酸中毒等急性併發症以及對生長發育的長期影響。持續血糖監測 (CGM) 系統、自動胰島素輸送 (AID) 設備和智慧胰島素幫浦等技術的進步，使得血糖水平管理更加精確和便捷。醫院、診所和家庭護理機構擴大將這些解決方案整合到護理方案中，以提高患者的依從性和臨床結果。父母、照顧者和醫療保健提供者對早期介入和有效糖尿病管理重要性的認知不斷提高，這也促進了市場的擴張。

市場概覽
預測期 2026-2030
2024年市場規模 56.6億美元
2030年市場規模 100.1億美元
2025-2030 年複合年成長率 9.94%
成長最快的領域 非連網設備
最大的市場 北美洲

市場受到多種關鍵因素的驅動。全球兒童糖尿病發生率的上升導致患者群體不斷擴大，需要持續監測和個人化照護。採用先進的胰島素輸送系統和連續血糖監測 (CGM) 設備可以更好地控制血糖，降低急性緊急情況和長期併發症的風險。醫療保健提供者正在強調以患者為中心的方法，根據兒童個別需求制定治療方案，並利用數位工具追蹤血糖水平、調整胰島素劑量並提供遠端監控。醫療技術的不斷進步，包括預測分析和數據驅動的決策，使臨床醫生能夠預測高風險事件並主動干預。醫療器材公司不斷增加研發投入，正在加速兒童糖尿病管理解決方案的創新，為病患和醫療保健專業人員提供更安全、更有效率、更便利的選擇。

市場新興趨勢包括互聯醫療技術的整合，該技術將連續血糖監測 (CGM)資料與胰島素輸送系統相結合，以實現即時調整。遠距醫療平台支援遠端監控和諮詢，幫助家庭在家中管理兒童糖尿病，同時減少就診次數。個人化治療方法，包括演算法驅動的胰島素給藥，正在提高護理的精確度和有效性。儘管成長前景強勁，但市場仍面臨諸多挑戰，例如某些地區的認知度有限、先進設備成本高昂（可能限制其普及性），以及需要對醫療保健專業人員進行專業培訓以有效使用這些技術。監管障礙以及對新設備長期安全性和有效性的擔憂可能會減緩其採用。透過教育、政策支援和技術創新來應對這些挑戰，對於維持全球兒童糖尿病管理市場的成長至關重要，從而確保糖尿病兒童獲得更好的治療結果。

關鍵市場促進因素

兒童糖尿病盛行率上升

主要市場挑戰

先進設備和療法的成本高昂

主要市場趨勢

數位健康解決方案整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球兒童糖尿病管理市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 副產物（血糖監測儀 (BGM)、連續血糖監測儀 (CGM)、胰島素幫浦、胰島素筆、胰島素注射器）
    • 按技術（連網設備、非連網設備）
    • 按最終使用者（醫院、家庭護理、兒科診所）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美兒童糖尿病管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲兒童糖尿病管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區兒童糖尿病管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲兒童糖尿病管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲兒童糖尿病管理市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Medtronic plc
  • DexCom, Inc.
  • Abbott Laboratories
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • Novo Nordisk A/S
  • Sanofi SA
  • Eli Lilly and Company
  • Roche Diabetes Care, Inc.
  • Ascensia Diabetes Care Holdings AG

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 30511

The Global Pediatric Diabetes Management Market was valued at USD 5.66 Billion in 2024 and is expected to reach USD 10.01 Billion by 2030 with a CAGR of 9.94%. The Global Pediatric Diabetes Management Market is witnessing significant growth due to the increasing prevalence of diabetes among children and adolescents, which is driving demand for innovative management solutions. Pediatric diabetes, particularly type 1 diabetes, requires continuous monitoring and precise insulin administration to prevent acute complications such as diabetic ketoacidosis and long-term effects on growth and development. Advances in technology, including continuous glucose monitoring (CGM) systems, automated insulin delivery (AID) devices, and smart insulin pumps, are enabling more precise and convenient management of blood glucose levels. Hospitals, clinics, and homecare settings are increasingly integrating these solutions into care protocols, improving patient adherence and clinical outcomes. Growing awareness among parents, caregivers, and healthcare providers regarding the importance of early intervention and effective diabetes management is also contributing to the market's expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.66 Billion
Market Size 2030USD 10.01 Billion
CAGR 2025-20309.94%
Fastest Growing SegmentNon-connected Devices
Largest MarketNorth America

The market is being driven by several key factors. Rising incidence of pediatric diabetes globally is creating a larger patient pool that requires continuous monitoring and personalized care. Adoption of advanced insulin delivery systems and CGM devices enables better glycemic control, reducing the risk of acute emergencies and long-term complications. Healthcare providers are emphasizing patient-centric approaches, tailoring treatment plans to individual children's needs, and leveraging digital tools to track glucose levels, adjust insulin dosing, and provide remote monitoring. Continuous advancements in medical technologies, including predictive analytics and data-driven decision-making, allow clinicians to anticipate high-risk episodes and intervene proactively. Increasing investments in research and development by medical device companies are accelerating innovation in pediatric diabetes management solutions, offering safer, more efficient, and user-friendly options for both patients and healthcare professionals.

Emerging trends in the market include the integration of connected healthcare technologies that combine CGM data with insulin delivery systems for real-time adjustments. Telemedicine platforms are supporting remote monitoring and consultation, helping families manage pediatric diabetes at home while reducing hospital visits. Personalized treatment approaches, including algorithm-driven insulin dosing, are enhancing the precision and effectiveness of care. Despite strong growth prospects, the market faces challenges such as limited awareness in certain regions, high costs of advanced devices that may restrict accessibility, and the need for specialized training of healthcare professionals to use these technologies effectively. Regulatory hurdles and concerns regarding long-term safety and efficacy of new devices may slow adoption. Addressing these challenges through education, policy support, and technological innovation is essential to sustaining growth in the Global Pediatric Diabetes Management Market, ensuring better outcomes for children living with diabetes.

Key Market Drivers

Rising Prevalence of Pediatric Diabetes

A major driver of the Global Pediatric Diabetes Management Market is the rising prevalence of pediatric diabetes, which has been increasing steadily due to a combination of genetic, environmental, and lifestyle factors. Type 1 diabetes remains the most common form among children and adolescents, requiring lifelong insulin therapy and continuous monitoring to prevent acute complications such as diabetic ketoacidosis (DKA) and long-term health issues affecting growth, cardiovascular health, and kidney function. At the same time, the incidence of type 2 diabetes is rising among younger populations, driven by childhood obesity, sedentary lifestyles, and poor dietary habits, creating an additional patient pool that requires regular monitoring, insulin therapy, and lifestyle interventions. According to the International Diabetes Federation, around 1.52 million people aged 20 years had diabetes in 2022, highlighting the significant burden of the disease and underscoring the urgent need for effective management solutions. This dual burden of type 1 and type 2 diabetes is intensifying demand for reliable pediatric diabetes management products and services.

Healthcare providers are recognizing the critical need for early diagnosis and intervention to manage glycemic levels efficiently and prevent complications. Continuous glucose monitoring (CGM) systems, automated insulin delivery (AID) devices, and smart insulin pumps are increasingly being adopted to provide real-time insights, personalized insulin dosing, and predictive alerts for hypoglycemic or hyperglycemic events. Rising prevalence is also driving investment in caregiver education programs and pediatric-specific treatment protocols, ensuring adherence to therapy and effective disease management. The increasing number of children diagnosed with diabetes is prompting healthcare systems, hospitals, and clinics to expand infrastructure, implement advanced monitoring solutions, and integrate digital health tools to improve patient outcomes. This growing patient base, combined with technological advancements and awareness initiatives, is a key factor propelling the expansion of the pediatric diabetes management market globally, reflecting the urgent need for specialized and accessible care solutions for young patients living with diabetes.

Key Market Challenges

High Cost of Advanced Devices and Therapies

A significant challenge facing the Global Pediatric Diabetes Management Market is the high cost of advanced devices and therapies, which limits accessibility for many families, particularly in low- and middle-income regions. Advanced technologies such as continuous glucose monitors (CGM), automated insulin delivery (AID) systems, and smart insulin pumps offer precision, convenience, and improved glycemic control, but their high purchase prices often ranging from USD 1,000-6,000 for pumps and USD 2,000-5,000 annually for CGM sensors create substantial financial barriers. Many families are unable to afford these technologies without adequate insurance coverage or government subsidies, resulting in disparities in pediatric diabetes care. The cost factor affects device adoption and long-term treatment adherence, as children relying on traditional finger-prick glucose meters and manual insulin injections face less precise monitoring, increasing the risk of acute complications such as diabetic ketoacidosis (DKA) and long-term health consequences.

High costs also constrain healthcare providers in standardizing advanced management solutions, especially in emerging markets with limited healthcare budgets. Manufacturers face the challenge of balancing innovation with affordability, as pediatric-specific R&D investments are substantial. To mitigate these barriers, strategies such as developing lower-cost alternatives, expanding insurance coverage, offering patient assistance programs, and implementing government subsidies are critical. Without such measures, the high expense of advanced devices and therapies will continue to impede adoption and limit the overall growth potential of the Global Pediatric Diabetes Management Market.

Key Market Trends

Integration of Digital Health Solutions

The integration of digital health solutions is a transformative trend in the Global Pediatric Diabetes Management Market, significantly enhancing the monitoring and management of pediatric diabetes. Digital health technologies, including mobile applications, cloud-based platforms, and telemedicine tools, allow caregivers and healthcare providers to access real-time data on blood glucose levels, insulin administration, and lifestyle factors. Continuous glucose monitoring (CGM) systems integrated with these platforms provide automated alerts for hypo- or hyperglycemic events, enabling timely interventions and reducing the risk of complications such as diabetic ketoacidosis. Integration of digital platforms with insulin pumps and automated insulin delivery (AID) systems further enhances personalized care by enabling real-time adjustments to insulin dosing based on predictive algorithms and trend analysis.

Remote monitoring capabilities offered by digital solutions allow healthcare professionals to supervise pediatric patients outside hospital settings, improving adherence and reducing the frequency of emergency visits or hospitalizations. These platforms also facilitate better communication between caregivers, patients, and clinicians, ensuring coordinated care and informed decision-making. Data collected through digital health systems can be analyzed to identify patterns in glucose fluctuations, evaluate the effectiveness of treatment protocols, and optimize long-term management strategies. Growing investment in healthcare IT infrastructure, increasing smartphone penetration, and rising awareness among parents and healthcare providers about the benefits of connected care are accelerating adoption of digital solutions. Integration of wearable sensors, artificial intelligence, and predictive analytics is enhancing the precision and efficiency of diabetes management, providing actionable insights and supporting proactive interventions. This convergence of technology and healthcare is shaping a patient-centric, data-driven approach, driving innovation and improving outcomes in pediatric diabetes management across diverse healthcare settings.

Key Market Players

  • Medtronic plc
  • DexCom, Inc.
  • Abbott Laboratories
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Eli Lilly and Company
  • Roche Diabetes Care, Inc.
  • Ascensia Diabetes Care Holdings AG

Report Scope:

In this report, the Global Pediatric Diabetes Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Diabetes Management Market, By Product:

  • Blood Glucose Monitors (BGM)
  • Continuous Glucose Monitors (CGM)
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes

Pediatric Diabetes Management Market, By Technology:

  • Connected Devices
  • Non-connected Devices

Pediatric Diabetes Management Market, By End User:

  • Hospitals
  • Homecare
  • Pediatric Clinics

Pediatric Diabetes Management Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Diabetes Management Market.

Available Customizations:

Global Pediatric Diabetes Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pediatric Diabetes Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Blood Glucose Monitors (BGM), Continuous Glucose Monitors (CGM), Insulin Pumps, Insulin Pens, Insulin Syringes)
    • 5.2.2. By Technology (Connected Devices, Non-connected Devices)
    • 5.2.3. By End User (Hospitals, Homecare, Pediatric Clinics)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Pediatric Diabetes Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pediatric Diabetes Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By End User
    • 6.3.2. Mexico Pediatric Diabetes Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By End User
    • 6.3.3. Canada Pediatric Diabetes Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By End User

7. Europe Pediatric Diabetes Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Pediatric Diabetes Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Pediatric Diabetes Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Pediatric Diabetes Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Pediatric Diabetes Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Pediatric Diabetes Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End User

8. Asia-Pacific Pediatric Diabetes Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Pediatric Diabetes Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End User
    • 8.3.2. India Pediatric Diabetes Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End User
    • 8.3.3. South Korea Pediatric Diabetes Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End User
    • 8.3.4. Japan Pediatric Diabetes Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Pediatric Diabetes Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End User

9. South America Pediatric Diabetes Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Pediatric Diabetes Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Pediatric Diabetes Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Pediatric Diabetes Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End User

10. Middle East and Africa Pediatric Diabetes Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Pediatric Diabetes Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Pediatric Diabetes Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Pediatric Diabetes Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic plc
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. DexCom, Inc.
  • 15.3. Abbott Laboratories
  • 15.4. Tandem Diabetes Care, Inc.
  • 15.5. Insulet Corporation
  • 15.6. Novo Nordisk A/S
  • 15.7. Sanofi S.A.
  • 15.8. Eli Lilly and Company
  • 15.9. Roche Diabetes Care, Inc.
  • 15.10. Ascensia Diabetes Care Holdings AG

16. Strategic Recommendations

17. About Us & Disclaimer